Ascendis Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
ASND Key Statistics
Stock Snapshot
Ascendis Pharma(ASND) stock is priced at $210.22, giving the company a market capitalization of 12.97B. It carries a P/E multiple of -51.12.
During the trading session on 2025-11-19, Ascendis Pharma(ASND) shares reached a daily high of $217.73 and a low of $208.01. At a current price of $210.22, the stock is +1.1% higher than the low and still -3.4% under the high.
Trading activity shows a volume of 542.24K, compared to an average daily volume of 701.46K.
Over the past 52 weeks, Ascendis Pharma(ASND) stock has traded between a high of $223.19 and a low of $118.03.
Over the past 52 weeks, Ascendis Pharma(ASND) stock has traded between a high of $223.19 and a low of $118.03.
ASND News
Wolfe Research initiated coverage of Ascendis Pharma (ASND) with an Outperform rating and $255 price target Yorvipath is off to a “strong” launch and “the party...
Ascendis Pharma (ASND) announced that pivotal Week 52 results from its randomized double-blind, placebo-controlled ApproaCH Trial of investigational once-weekly...
Ascendis Pharma reported third-quarter 2025 results showing revenue of €213.63 million and a net loss of €60.99 million, with improved financial performance, gl...
Analyst ratings
100%
of 15 ratingsMore ASND News
Ascendis Pharma (NasdaqGS:ASND) has caught the attention of investors, with shares fluctuating over the past month. The company’s stock performance reflects shi...
Analyst Yun Zhong from Wedbush maintained a Buy rating on Ascendis Pharma and increased the price target to $220.00 from $212.00. Meet Your ETF AI Analyst Disco...